National Center for Advancing Translational Sciences

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
National Center for Advancing Translational Sciences (NCATS)
AbbreviationNCATS
Formation2011
TypeU.S. government agency
Legal statusActive
HeadquartersBethesda, Maryland
Region served
 United States
Official language
English
Director
Christopher P. Austin, M.D.
Parent organization
National Institutes of Health
AffiliationsUnited States Public Health Service
Websitehttp://www.ncats.nih.gov

The National Center for Advancing Translational Sciences (NCATS) was established in 2012[1] and is located in Bethesda, Maryland. The NCATS is one of 27 institutes and centers of the US National Institutes of Health (NIH), an agency of the US Department of Health and Human Services. The mission of NCATS is to transform the translation of scientific discoveries so that new treatments and cures for disease can be delivered to patients faster. The budget provided to NCATS for fiscal year 2018 is $557,373,000.[2]

History[edit]

NCATS was created in December 2011 by the Consolidated Appropriations Act, 2012.[3]

The center was created from a number of existing NIH programs:[4]

Divisions[edit]

NCATS is organized into a number of divisions:

  • Division of Clinical Innovation
  • Division of Pre-Clinical Innovation
  • Office of Administrative Management
  • Office of Grants Management and Scientific Review
  • Office of Rare Diseases Research
Oversees the Rare Diseases Clinical Research Network and Genetic and Rare Diseases Information Center (GARD)[7]
  • Office of Strategic Alliances
Works with businesses in the biotech and pharmaceutical industry to speed the development of new drugs[7]

See also[edit]

References[edit]

  1. ^ Wadman, Meredith (12 January 2012). "US translational-science centre gets under way". Nature. 481 (7380): 128–128. doi:10.1038/481128a.
  2. ^ "Budget". National Center for Advancing Translational Sciences. 12 March 2015.
  3. ^ [1][dead link]
  4. ^ Wadman, Meredith (12 January 2012). "US translational-science centre gets under way". Nature. 481 (7380): 128–128. doi:10.1038/481128a.
  5. ^ "NIH's Cures Acceleration Network (CAN) - Rare Disease Legislative Advocates". 12 May 2010.
  6. ^ "Cures Acceleration Network (CAN) Review Board - National Center for Advancing Translational Sciences". National Center for Advancing Translational Sciences.
  7. ^ a b "Divisions & Offices". National Center for Advancing Translational Sciences. 12 March 2015.